Maartje W. Rohaan

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

Stefano Trebeschi, Silvia Girolama Drago, Nicolai J. Birkbak et al. · Annals of Oncology · 2019 · 558 citations · Full text

Medicine, Oncology, Radiology +17

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 536 citations · Full text

Medicine, Immunology, Oncology +17

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

C. Owen, Alexander N. Shoushtari, D Chauhan et al. · Annals of Oncology · 2020 · 110 citations · Full text

Medicine, Immunology, Oncology +14

Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR

Stéphanie A. Blankenstein, Maartje W. Rohaan, W. Martin C. Klop et al. · Annals of Surgery · 2021 · 47 citations · Full text

Medicine, Oncology, Surgery +17

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

Maartje W. Rohaan, Raquel Gomez-Eerland, Joost H. van den Berg et al. · Immuno-Oncology Technology · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +17